Medicare Advantage Plans Often Deny Needed Care, Federal Report Finds

Every year, tens of thousands of people enrolled in private Medicare Advantage plans are denied necessary care that should be covered under the program, federal investigators concluded in a report…

Medicare Will Only Cover New Alzheimer’s Drug in Trials

April 8, 2022 — Federal officials have made their final decision: Medicare will only pay for patients to get the new Alzheimer’s drug aducanumab (Aduhelm) if the patients are participating…

Medicare Will Provide Free At-Home COVID-19 Tests Soon

Feb. 4, 2022 Medicare will cover the cost of over-the-counter rapid COVID-19 tests beginning in the “early spring,” according to an announcement from the Centers for Medicare & Medicaid Services…

Medicare Seeks to Cut Drug Costs for People in Part D Plans

Jan. 7, 2022 — The Biden administration said this week it intends to challenge insurance companies to deliver better service to people enrolled in Medicare, including applying discounts on drugs…

Alzheimer’s Drug Aduhelm Faces Crucial Medicare Decision

Posts supporting coverage include comments from people who have consulted for Biogen, like Dr. Jeffrey Cummings, a research professor in the department of brain health at the University of Nevada…